We are live on ! Find out more
IMCC

IM Cannabis

30 hedge funds and large institutions have $5.67M invested in IM Cannabis in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.22%0.22% (+0%)

6% less funds holding

Funds holding: 3230 (-2)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

71% less capital invested

Capital invested by funds: $19.4M → $5.67M (-$13.8M)

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
9
Reduced
10
Closed
4
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$3K

IMCC Hedge Fund Activity: Q2 2022 in Review

30 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in IM Cannabis (IMCC) for Q2 2022, worth a combined $5.67M — down 71% from $19.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMCC and 2 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Mirae Asset Global Investments, adding an estimated $418K. The largest seller was Wasatch Advisors, cutting an estimated $338K.

  • 30 institutional investors held IM Cannabis (IMCC) as of Q2 2022, down from 32 in Q1 2022.
  • Funds reported $5.67M of IM Cannabis stock for Q2 2022, down 71% quarter-over-quarter.
  • 2 funds opened new IM Cannabis positions in Q2 2022 and 4 closed out, a net change of -2 holders.
  • The largest IM Cannabis buyer in Q2 2022 was Mirae Asset Global Investments, an estimated $418K added.
  • The largest IM Cannabis seller in Q2 2022 was Wasatch Advisors, an estimated $338K sold.

Based on aggregated 13F filings for Q2 2022.